Advaxis Inc (NASDAQ:ADXS) - Share price - Overview

Stock Report

Advaxis Inc ADXS

Last Price
$3.00

Day Change
-0.08|-2.60%

As of 21/11/2017
16:00:06 EST | USD
Minimum 15 Minutes Delay.

Last Close3.08
Day Range2.98 - 3.15
Mkt Cap126.50Mil
52-Wk Range2.83 - 10.06
Yield %-
ISINUS0076242082
Volume380,274
P/E-1.30
P/S8.81
P/CF-3.30

Share Price

Financials
201420152016
More ...
Income Statement
Revenue1.000.003.99
Operating Income-19.54-48.67-76.49
Net Income-16.53-47.03-73.56
Basic EPS-0.97-1.68-2.08
Avg. Diluted Shares Outstanding172835
Balance Sheet
Current Assets20.49115.01159.88
Non Current Assets2.884.599.17
Total Assets23.38119.61169.04
Current Liabilities2.723.9227.71
Total Liabilities2.754.0149.74
Total Equity20.63115.60119.30
Cash Flow
Operating Cash Flow-17.02-24.14-9.07
Capital Expenditure-0.44-1.79-4.45
Free Cash Flow-17.46-25.93-13.52

In millions, except "Basic EPS". Currency is USD.

Company Profile

Advaxis Inc focuses on discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

October

Employees

90
Key Stats
More ...
Price/Earning TTM-1.34
Price/Book1.70
Price/Sales TTM10.83
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % TTM-1,914.77
Net Margin % TTM-1,841.27
ROE TTM-62.63
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.